Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other Working Capital Changes: 2012-2024

Historic Other Working Capital Changes for Rocket Pharmaceuticals (RCKT) over the last 13 years, with Dec 2024 value amounting to $661,000.

  • Rocket Pharmaceuticals' Other Working Capital Changes fell 358.39% to -$739,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year increase of 64.49%. This contributed to the annual value of $661,000 for FY2024, which is 124.54% up from last year.
  • Per Rocket Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $661,000 for FY2024, which was up 124.54% from -$2.7 million recorded in FY2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Other Working Capital Changes peaked at $3.6 million during FY2022, and registered a low of -$2.7 million during FY2023.
  • Its 3-year average for Other Working Capital Changes is $520,000, with a median of $661,000 in 2024.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 186.16% in 2021, then surged by 374.90% in 2022.
  • Over the past 5 years, Rocket Pharmaceuticals' Other Working Capital Changes (Yearly) stood at $1.5 million in 2020, then tumbled by 186.16% to -$1.3 million in 2021, then skyrocketed by 374.90% to $3.6 million in 2022, then crashed by 174.98% to -$2.7 million in 2023, then spiked by 124.54% to $661,000 in 2024.